Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.48278 | 79 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 6.24086 | 84 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.57698 | 79 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.93317 | 81 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.86973 | 81 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.44822 | 80 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.516 | 80 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.94252 | 75 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.10611 | 76 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.68782 | 80 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.83356 | 81 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.5806 | 79 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.29601 | 78 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.68462 | 80 |